Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02985684 · ClinicalTrials.gov registry record · NA
Safety and Efficacy Study of Transcatheter Closure of Ostium Secundum ASDs
A NA study, sponsored by W.L.Gore & Associates.
- Completed
- Registry status
- NA
- Development phase
- 125
- Enrollment target
NCT02985684 is a NA study that has completed, run by W.L.Gore & Associates. The registered enrollment target is 125 participants.
The verdict
NCT02985684, a NA study, has completed, sponsored by W.L.Gore & Associates.
- COMPLETED
- Registry status
- NA
- Development phase
- 125 participants
- Enrollment target
Study Summary
Evaluate the safety and efficacy of the GORE® CARDIOFORM ASD Occluder in the percutaneous closure of ostium secundum atrial septal defects (ASDs)
Interventions
- DEVICE GORE® CARDIOFORM ASD Occluder
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 125 participants |
| Start Date | 2017-03-10 |
| Est. Completion | 2022-09-29 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02985684
The ClinicalTrials.gov registry entry for NCT02985684 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 125 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is W.L.Gore & Associates, which has 53 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which GORE® CARDIOFORM ASD Occluder is the first listed.
NCT02985684 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02985684 about?
NCT02985684 is a clinical study titled "Safety and Efficacy Study of Transcatheter Closure of Ostium Secundum ASDs". Evaluate the safety and efficacy of the GORE® CARDIOFORM ASD Occluder in the percutaneous closure of ostium secundum atrial septal defects (ASDs)
What is the current status of trial NCT02985684?
This trial is currently completed. It is a NA study. The enrollment target is 125 participants. The study started on 2017-03-10. Estimated completion is 2022-09-29.
What interventions are being tested in trial NCT02985684?
The interventions under investigation include: GORE® CARDIOFORM ASD Occluder (DEVICE).
Who is sponsoring clinical trial NCT02985684?
This trial is sponsored by W.L.Gore & Associates, which has 53 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.